Ирина Зайдман

Научные публикации

• Sclerotic-Type Cutaneous Chronic Graft-Versus-Host Disease Exhibits Activation of T Helper 1 and OX40 Cytokines
• High rate of adenovirus detection in gastrointestinal biopsies of symptomatic stem cell transplant recipients
• Risk and promise: an 11-year, single-center retrospective study of severe acute GVHD in pediatric patients undergoing allogeneic HSCT for nonmalignant diseases
• SURVIVAL OF PEDIATRIC PATIENTS WITH NON-MALIGNANT DISEASES REQUIRING HOSPITALIZATION IN THE INTENSIVE CARE UNIT FOLLOWING HEMATOPOIETIC STEM CELL TRANSPLANTATION AND RISK FACTORS FOR MORTALITY
• STEM CELL TRANSPLANTATIONS FOR PATIENTS WITH FANCONI ANEMIA: AN ISRAELI TERTIARY CENTER EXPERIENCE
• Neurological complications following pediatric allogeneic hematopoietic stem cell transplantation: Risk factors and outcome
• Vedolizumab for pediatric patients with gastrointestinal acute graft-versus-host-disease
• Incremental donor lymphocyte infusion to treat mixed chimerism after allogeneic stem cell transplantation in children with non-malignant diseases
• Two decades of stem cell transplantation in patients with Fanconi anemia: Analysis of factors affecting transplant outcomes
• Autoimmune Cytopenias Post Hematopoietic Stem Cell Transplantation in Pediatric Patients With Osteopetrosis and Other Nonmalignant Diseases
• Survival of pediatric patients requiring admission in the intensive care unit post hematopoietic stem cell transplantation: Prognostic factors associated with mortality
• Clinical presentation and analysis of genotype-phenotype correlations in patients with malignant infantile osteopetrosis
• The Clinical Aspect of Adaptor Molecules in T Cell Signaling: Lessons Learnt From Inborn Errors of Immunity
• Evaluation of gastrointestinal symptoms in pediatric patients post hematopoietic stem cell transplantation: Ileo-colonoscopy versus sigmoidoscopy. A single-center experience and review of literature
• Improved transplant outcomes with myeloablative conditioning for hemophagocytic lymphohistiocytosis in HLA-matched and mismatched donors: a national multicenter retrospective study
• Hematopoietic stem cell transplantation for mitochondrial neurogastrointestinal encephalopathy: A single-center experience underscoring the multiple factors involved in the prognosis
• Bacillus Calmette-Guerin (BCG) Vaccine-associated Complications in Immunodeficient Patients Following Stem Cell Transplantation
• Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): Position paper on diagnosis, prognosis, and treatment by the MNGIE International Network
• Haploidentical stem cell transplantation with post-transplant cyclophosphamide for osteopetrosis and other nonmalignant diseases
• Skin toxicity following treosulfan-thiotepa-fludarabine-based conditioning regimen in non-malignant pediatric patients undergoing hematopoietic stem cell transplantation
• The Broad Clinical Spectrum and Transplant Results of PNP Deficiency
• Successful treatment with daratumumab for post-HSCT refractory hemolytic anemia
• Primary Cutaneous Clonal CD8+ T-Cell Lymphoproliferative Disorder Associated With Immunodeficiency due to RAG1 Mutation
• Stem cell transplantation for osteopetrosis in patients beyond the age of 5 years
• Management of XLP-1 and ITK deficiency: The challenges posed by PID with an unpredictable spectrum of disease manifestations
• Varroa chemosensory proteins: some are conserved across Arthropoda but others are arachnid specific
• Respiratory manifestations in LPS-responsive beige-like anchor (LRBA) protein-deficient patients
• Successful hematopoietic stem cell transplantation for osteopetrosis using reduced intensity conditioning
• Chemosensing of honeybee parasite, Varroa destructor: Transcriptomic analysis
• Correction: Early onset combined immunodeficiency and autoimmunity in patients with loss-of-function mutation in LAT
• Early onset combined immunodeficiency and autoimmunity in patients with loss-of-function mutation in LAT
• Treosulfan-based conditioning for allogeneic HSCT in children with chronic granulomatous disease: a multicenter experience
• Safety and Role of Gastrointestinal Endoscopy in the Management of Gastrointestinal Acute GVHD in Children After Hematopoietic Stem Cell Transplantation
• Allogeneic Stem Cell Transplantation in Congenital Hemoglobinopathies Using a Tailored Busulfan-Based Conditioning Regimen: Single-Center Experience
• Infections and neutrophils in the pathogenesis of bronchiolitis obliterans syndrome in children after allogeneic stem cell transplantation
• Human Herpes Virus-6 Following Pediatric Allogeneic Hematopoietic Stem Cell Transplantation
• Serum Krebs Von Den Lungen-6 as a Biomarker for Early Detection of Bronchiolitis Obliterans Syndrome in Children Undergoing Allogeneic Stem Cell Transplantation
• Serum galactomannan screening for diagnosis of invasive pulmonary aspergillosis in children after stem cell transplantation or with high-risk leukemia
• Hematopoietic stem cell transplantation in infants
• Bone marrow transplantation for non-malignant diseases using treosulfan-based conditioning
• The outcome of allogeneic hematopoietic cell transplantation for children with FMS-like tyrosine kinase 3 internal tandem duplication-positive acute myelogenous leukemia
• Mycobacterium phocaicum bacteremia: an emerging infection in pediatric hematology-oncology patients
• Autoimmune complications after hematopoietic stem cell transplantation in children with nonmalignant disorders
• Molecular-based diagnosis of bacteremia in the setting of fever with or without neutropenia in pediatric hematology-oncology patients
• Analysis of risk factors of cord blood transplantation for children
• Impact of conditioning on outcome of hematopoietic stem cell transplantation for wiskott-Aldrich syndrome
• Legionella pneumonia in a child with leukemia
• Detection, control, and management of a respiratory syncytial virus outbreak in a pediatric hematology-oncology department
• Factors influencing outcome and incidence of late complications in children who underwent allogeneic hematopoietic stem cell transplantation for hemoglobinopathy
• Polyserositis as a manifestation of graft-versus-host disease